JP2012532739A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012532739A5 JP2012532739A5 JP2012520713A JP2012520713A JP2012532739A5 JP 2012532739 A5 JP2012532739 A5 JP 2012532739A5 JP 2012520713 A JP2012520713 A JP 2012520713A JP 2012520713 A JP2012520713 A JP 2012520713A JP 2012532739 A5 JP2012532739 A5 JP 2012532739A5
- Authority
- JP
- Japan
- Prior art keywords
- body member
- engineered
- nanoparticle body
- processed
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002105 nanoparticle Substances 0.000 claims description 53
- 239000002245 particle Substances 0.000 claims description 52
- 238000005096 rolling process Methods 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 229940124597 therapeutic agent Drugs 0.000 claims description 7
- 239000000443 aerosol Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- -1 taggant Substances 0.000 claims description 4
- 239000002872 contrast media Substances 0.000 claims description 3
- 239000000032 diagnostic agent Substances 0.000 claims description 3
- 229940039227 diagnostic agent Drugs 0.000 claims description 3
- 239000003124 biologic agent Substances 0.000 claims description 2
- 210000003169 central nervous system Anatomy 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000000696 magnetic material Substances 0.000 claims description 2
- 239000002907 paramagnetic material Substances 0.000 claims description 2
- 238000005191 phase separation Methods 0.000 claims description 2
- 230000002685 pulmonary effect Effects 0.000 claims description 2
- 230000019491 signal transduction Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 description 7
- 239000011344 liquid material Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22513809P | 2009-07-13 | 2009-07-13 | |
| US61/225,138 | 2009-07-13 | ||
| PCT/US2010/041797 WO2011008737A2 (en) | 2009-07-13 | 2010-07-13 | Engineered aerosol particles, and associated methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014182213A Division JP6189807B2 (ja) | 2009-07-13 | 2014-09-08 | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012532739A JP2012532739A (ja) | 2012-12-20 |
| JP2012532739A5 true JP2012532739A5 (https=) | 2013-08-15 |
| JP5656996B2 JP5656996B2 (ja) | 2015-01-21 |
Family
ID=42818752
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012520713A Expired - Fee Related JP5656996B2 (ja) | 2009-07-13 | 2010-07-13 | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 |
| JP2014182213A Active JP6189807B2 (ja) | 2009-07-13 | 2014-09-08 | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014182213A Active JP6189807B2 (ja) | 2009-07-13 | 2014-09-08 | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20120114554A1 (https=) |
| EP (1) | EP2454011A2 (https=) |
| JP (2) | JP5656996B2 (https=) |
| WO (1) | WO2011008737A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9057712B1 (en) | 2011-10-27 | 2015-06-16 | Copilot Ventures Fund Iii Llc | Methods of delivery of encapsulated perfluorocarbon taggants |
| US20150037428A1 (en) * | 2011-11-29 | 2015-02-05 | The University Of North Carolina At Chapel Hill | Geometrically engineered particles and methods for modulating macrophage or immune responses |
| CN107614565B (zh) * | 2015-04-21 | 2021-04-09 | Ran生物技术公司 | 氟化表面活性剂 |
| UY36851A (es) | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | Compuestos para uso en aplicaciones antibacterianas |
| AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
| WO2017035408A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
| BR112018009899A8 (pt) | 2015-11-18 | 2019-02-26 | Glaxosmithkline Ip No 2 Ltd | composição, inalador, forma de dosagem única, métodos para fabricar partículas, para melhorar as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a incidência das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a gravidade das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir uma infecção respiratória viral e para fabricar uma partícula de inalação de pó seco de ribavirina controlada na forma polimorfa cristalina, partículas fabricadas, método de tratamento, pluralidade de partículas, e, recipiente de dose. |
| CN109039582A (zh) * | 2016-04-28 | 2018-12-18 | 王志 | 一种输出Lorenz型吸引子的简单混沌系统电路 |
| US10898494B2 (en) | 2016-05-05 | 2021-01-26 | Liquidia Technologies, Inc. | Dry powder treprostinil for the treatment of pulmonary hypertension |
| CN109790143A (zh) | 2016-05-10 | 2019-05-21 | C4医药公司 | 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体 |
| RU2018145364A (ru) | 2016-06-27 | 2020-07-28 | Ачиллион Фармасьютикалс, Инк. | Хиназолиновые и индольные соединения для лечения медицинских нарушений |
| CN110603252A (zh) | 2017-03-01 | 2019-12-20 | 艾其林医药公司 | 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物 |
| EP4717317A2 (en) | 2017-06-20 | 2026-04-01 | C4 Therapeutics, Inc. | N/o-linked degrons and degronimers for protein degradation |
| JP2021519337A (ja) | 2018-03-26 | 2021-08-10 | シー４ セラピューティクス， インコーポレイテッド | Ｉｋａｒｏｓの分解のためのセレブロン結合剤 |
| WO2020041301A1 (en) | 2018-08-20 | 2020-02-27 | Achillion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement factor d medical disorders |
| WO2020051532A2 (en) | 2018-09-06 | 2020-03-12 | Achillion Pharmaceuticals, Inc. | Macrocyclic compounds for the treatment of medical disorders |
| EP3866773B1 (en) | 2018-10-16 | 2024-08-28 | Georgia State University Research Foundation, Inc. | Carbon monoxide prodrugs for the treatment of medical disorders |
| WO2021168320A1 (en) | 2020-02-20 | 2021-08-26 | Achillion Pharmaceuticals, Inc. | Heteroaryl compounds for treatment of complement factor d mediated disorders |
| AU2021231898A1 (en) | 2020-03-05 | 2022-10-27 | C4 Therapeutics, Inc. | Compounds for targeted degradation of BRD9 |
| WO2022066774A1 (en) | 2020-09-23 | 2022-03-31 | Achillion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement mediated disorders |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| DE69430303T2 (de) | 1991-03-05 | 2002-11-28 | Aradigm Corp | Verfahren und vorrichtung zur korrektur eines nullsignals eines drucksensors fur einen durchflussmesser |
| WO1993000951A1 (en) | 1991-07-02 | 1993-01-21 | Inhale, Inc. | Method and device for delivering aerosolized medicaments |
| US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
| US5558085A (en) | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
| US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| US5497763A (en) | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
| CZ289029B6 (cs) | 1994-09-21 | 2001-10-17 | Inhale Therapeutic Systems | Způsob aerosolizace práąku, zejména práąkového léku a zařízení k provádění tohoto způsobu |
| US5780014A (en) | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
| EP1700161B1 (en) * | 2003-12-01 | 2018-01-24 | The Board of Trustees of the University of Illinois | Methods and devices for fabricating three-dimensional nanoscale structures |
| DK1704585T3 (en) | 2003-12-19 | 2017-05-22 | Univ North Carolina Chapel Hill | Methods for preparing isolated micro- and nanostructures using soft lithography or printing lithography |
| WO2007030698A2 (en) * | 2005-09-07 | 2007-03-15 | The University Of North Carolina At Chapel Hill | Materials and methods for fabricating isolated micro-and nano-structures having chemical functionality |
| WO2006130943A1 (en) * | 2005-06-10 | 2006-12-14 | The Governors Of The University Of Alberta | Respirable dried powder formulation comprising drug loaded nanoparticles |
| MX2007016039A (es) * | 2005-06-17 | 2008-10-27 | Univ North Carolina | Metodos, sistemas y materiales de fabricacion de nanoparticulas. |
| EP1951202A4 (en) * | 2005-11-07 | 2013-03-06 | Univ North Carolina | ISOLATED AND SOLID MICRO AND NANO STRUCTURES AND METHOD THEREFOR |
| WO2008011051A1 (en) * | 2006-07-17 | 2008-01-24 | Liquidia Technologies, Inc. | Nanoparticle fabrication methods, systems, and materials |
| US20100055459A1 (en) * | 2006-08-30 | 2010-03-04 | Liquidia Technologies, Inc. | Nanoparticles Having Functional Additives for Self and Directed Assembly and Methods of Fabricating Same |
| US7875654B2 (en) * | 2007-03-23 | 2011-01-25 | The Board Of Trustees Of The University Of Illinois | System for forming janus particles |
-
2010
- 2010-07-13 US US13/383,518 patent/US20120114554A1/en not_active Abandoned
- 2010-07-13 WO PCT/US2010/041797 patent/WO2011008737A2/en not_active Ceased
- 2010-07-13 JP JP2012520713A patent/JP5656996B2/ja not_active Expired - Fee Related
- 2010-07-13 EP EP10742329A patent/EP2454011A2/en not_active Ceased
-
2014
- 2014-09-08 JP JP2014182213A patent/JP6189807B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012532739A5 (https=) | ||
| Cojocaru et al. | Nanoparticle-based drug delivery systems in inhaled therapy: improving respiratory medicine | |
| JP6189807B2 (ja) | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 | |
| Malamatari et al. | Spray drying for the preparation of nanoparticle-based drug formulations as dry powders for inhalation | |
| Heng et al. | The nano spray dryer B-90 | |
| Bakhtiary et al. | Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer | |
| Paris et al. | Mesoporous silica nanoparticles for co-delivery of drugs and nucleic acids in oncology: A review | |
| Peng et al. | Nano-formulations for pulmonary delivery: Past, present, and future perspectives | |
| Kumar et al. | Nanomedicine in drug delivery | |
| Oberdörster et al. | Nanoparticles and the brain: cause for concern? | |
| CN101479051B (zh) | 生产多层粒子、纤维和喷雾的系统和方法以及施用它们的方法 | |
| Anton et al. | Trojan microparticles for drug delivery | |
| Garello et al. | Micro/nanosystems for magnetic targeted delivery of bioagents | |
| CN108578372A (zh) | 微晶二酮哌嗪组合物以及方法 | |
| Dua et al. | Targeting microRNAs using nanotechnology in pulmonary diseases. | |
| Tomoda et al. | Preparation and properties of inhalable nanocomposite particles: effects of the temperature at a spray-dryer inlet upon the properties of particles | |
| Negi et al. | Engineering inhalable therapeutic particles: conventional and emerging approaches | |
| Du et al. | Breath and beyond: advances in nanomedicine for oral and intranasal aerosol drug delivery | |
| Keil et al. | Evaluation of adsorption of DNA/PEI polyplexes to tubing materials | |
| Kwak et al. | Microfluidic Platforms for Ex Vivo and In Vivo Gene Therapy | |
| CN102365126B (zh) | 用于生产包覆粒子的工艺和设备 | |
| Pawara et al. | Spray Dried Nanoparticle for Pulmonary Delivery: Current Developments and Future Perspectives. | |
| Dangova et al. | Nanocarriers-assisted nose-to-brain delivery of levodopa: Current progress and prospects | |
| Donovan et al. | Novel dry powder inhaler particle-dispersion systems | |
| CN104116712B (zh) | 一种用于肺部给药的干扰素‑白蛋白中空性纳米聚集颗粒 |